References
- The Global asthma Network, “the Global asthma report 2022. 2022. Accessed: Sep. 10, 2023. Available: http://globalasthmareport.org/
- Al Meslamani AZ. How does sleep influence asthma through immunity? Expert Rev Clin Immunol. 1–4. doi: 10.1080/1744666X.2023.2284213
- Al Meslamani AZ. Insights into the immunological links between dietary habits and asthma. Expert Rev Clin Immunol. 1–4. doi: 10.1080/1744666X.2023.2277864
- Calhoun WJ, Chupp GL. The new era of add-on asthma treatments: where do we stand? Allergy, Asthma Clin Immunol. 2022;18(1):42. doi: 10.1186/s13223-022-00676-0
- Albertson TE, Pugashetti JV, Chau-Etchepare F, et al. Pharmacotherapeutic management of asthma in the elderly patient. Expert Opin Pharmacother. 2020 Nov;21(16):1991–2010. doi: 10.1080/14656566.2020.1795131
- Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax. 2004;59(2):94–99. doi:10.1136/thorax.2003.011858
- Khan R, Maharaj R, Seerattan N, et al. Effectiveness of personalized written asthma action plans in the management of children with partly controlled asthma in Trinidad: a randomized controlled trial. J Trop Pediatr. 2014 Feb;60(1):17–26. doi: 10.1093/tropej/fmt063
- Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008 Sep;372(9643):1107–1119. doi: 10.1016/S0140-6736(08)61452-X
- Szefler SJ, Chipps B. Challenges in the treatment of asthma in children and adolescents. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2018 Apr;120(4):382–388. doi: 10.1016/j.anai.2018.01.003
- Nwaru BI, Ekström M, Hasvold P, et al. Overuse of short-acting β 2 -agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020 Apr;55(4):1901872. doi: 10.1183/13993003.01872-2019
- Quint JK, Arnetorp S, Kocks JWH, et al. Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2297–2309.e10. doi: 10.1016/j.jaip.2022.02.047
- Harrison P, Duggan W, Preddy J, et al. Asthmatic children from lower-income families are less likely to own an individualised asthma action plan. J Paediatr Child Health. 2020 Feb;56(2):194–200. doi: 10.1111/jpc.14553
- Chen W, Lynd LD, FitzGerald JM, et al. Influences of socioeconomic status on costs of asthma under universal health coverage. Med Care. 2016 Aug;54(8):789–795. doi: 10.1097/MLR.0000000000000563
- Brusselle GG, Koppelman GH, Taichman DB. Biologic therapies for severe asthma. N Engl J Med. 2022 Jan;386(2):157–171. doi: 10.1056/NEJMra2032506
- Pelaia C, Crimi C, Vatrella A, et al. Molecular targets for biological therapies of severe asthma. Front Immunol. 2020;11:603312. doi: 10.3389/fimmu.2020.603312
- Makhinova T, Barner JC, Brown CM, et al. Improving asthma management: patient–Pharmacist partnership program in enhancing therapy adherence. Pharm (Basel, Switzerland). 2022 Feb;10(1):34. doi: 10.3390/pharmacy10010034
- Eck S, Hapfelmeier A, Linde K, et al. Effectiveness of an online education program for asthma patients in general practice: study protocol for a cluster randomized controlled trial. BMC Pulm Med. 2022;22(1):457. doi: 10.1186/s12890-022-02217-2
- Gums TH, Carter BL, Milavetz G, et al. Physician-pharmacist collaborative management of asthma in primary care. Pharmacotherapy. 2014 Oct;34(10):1033–1042. doi: 10.1002/phar.1468
- Abdel-Qader DH, Hayajneh W, Albassam A, et al. Pharmacists-physicians collaborative intervention to reduce vaccine hesitancy and resistance: a randomized controlled trial. Vaccine: X. 2022 Apr;10:100135.
- Al Meslamani AZ. How AI is advancing asthma management? insights into economic and clinical aspects. J Med Econ. 1–9. doi: 10.1080/13696998.2023.2277072